CMD03 CAR T Cell

· Chulalongkorn University

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CMD03 CAR T Cell, covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of CMD03 CAR T Cell in Children With Relapse or Refractory Solid Tumors [Phase 1]